Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Therapeutic Target Considerations

Therapeutic target or treatment hypotheses submitted to the FDA as part of investigational new drug (IND) applications [Pg.28]

For Every 4 Clinical NDCs (f) Trial Tested Procession Rate For Each NDC— Projected Procession Rate (Eraction) [Pg.29]

New Drug Candidate Indications Being Tested status Sponsor [Pg.29]

IC351 Male erectile dysfunction NDA filed ICOS/Lily [Pg.29]

Denileukin diftitox Cutaneous T cell lymphoma Phase II Phase III Ligands [Pg.29]

Xing Z, WJ. Consideration of cytokines as therapeutic targets. Curr Pharm Design 2000 599-611. [Pg.274]

See other pages where Therapeutic Target Considerations is mentioned: [Pg.21] [Pg.28] [Pg.29] [Pg.31] [Pg.33] [Pg.21] [Pg.28] [Pg.29] [Pg.31] [Pg.33] [Pg.46] [Pg.4] [Pg.319] [Pg.379] [Pg.392] [Pg.229] [Pg.235] [Pg.118] [Pg.271] [Pg.148] [Pg.15] [Pg.782] [Pg.202] [Pg.1320] [Pg.1320] [Pg.102] [Pg.6] [Pg.79] [Pg.128] [Pg.262] [Pg.222] [Pg.823] [Pg.154] [Pg.156] [Pg.443] [Pg.404] [Pg.285] [Pg.78] [Pg.264] [Pg.271] [Pg.367] [Pg.149] [Pg.176] [Pg.176] [Pg.109] [Pg.814] [Pg.73] [Pg.16] [Pg.62] [Pg.286] [Pg.290] [Pg.390] [Pg.20]

SEARCH

Target Safety Assessments Evaluation of Undesired Pharmacology and Therapeutic Area Considerations

Targeted therapeutics

Targets targeted therapeutics

Therapeutic targeting

Therapeutic targets